Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain https://lnkd.in/d4GwZimm
Congratulations Hoba Therapeutics! We are delighted to join you on this journey to deliver hope to patients worldwide!
Congratulatins
Vice President at Novo Holdings | Seed Investments
10moVery much looking forward to join the team!